E. Read-Connole

发表

Phase 2 study of pegylated liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi sarcoma.

S. Steinberg, S. Pittaluga, R. Yarchoan, 2007, Blood.

T4 POSITIVE HUMAN NEOPLASTIC CELL LINES SUSCEPTIBLE TO AND PERMISSIVE FOR HTLV-III

M. Popovič, E. Read-Connole, RobertC. Gallo, 1984, The Lancet.

Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus.

A. Blauvelt, D. Davis, R. Yarchoan, 2001, Blood.

Origin of the HIV-susceptible human CD4+ cell line H9.

S. O’Brien, A. Gazdar, D. Mann, 1989, AIDS research and human retroviruses.

Phase II Study of Pegylated Liposomal Doxorubicin in Combination with Interleukin-12 for AIDS-Related Kaposi’s Sarcoma Running head: IL-12 AND LIPOSOMAL DOXORUBICIN FOR KAPOSI’S SARCOMA

S. Steinberg, S. Pittaluga, R. Yarchoan, 2007 .

HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens.

W. Blattner, P. Wernet, L. Arthur, 1988, Journal of immunology.

Oxidative Modifications of Kynostatin-272, a Potent Human Immunodeficiency Virus Type 1 Protease Inhibitor: Potential Mechanism for Altered Activity in Monocytes/Macrophages

H. Fales, D. Davis, R. Yarchoan, 2002, Antimicrobial Agents and Chemotherapy.

Nucleotide Sequences Homologous to Mammalian Proto-oncogenes and Their Expression in Fish Cell Lines

C. Smith, F. Hetrick, E. Read-Connole, 1990 .

RNA editing, epitranscriptomics, and processing in cancer progression

J. Steitz, S. Jaffrey, J. Coffin, 2015, Cancer biology & therapy.

On the historical origins of HIV-1 (MN) and (RF).

J. Hoxie, M. Reitz, R. Gallo, 1992, AIDS Research and Human Retroviruses.